|
Fonar Corporation (FONR) Évaluation DCF
US | Healthcare | Medical - Devices | NASDAQ
|
- ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
- ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
- ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
- ✓ Aucune Expertise N'Est Requise; Facile À Suivre
FONAR Corporation (FONR) Bundle
Gardez un aperçu de votre analyse de l'évaluation de votre Fonar Corporation (FONR) à l'aide de notre calculatrice sophistiquée DCF! Ce modèle Excel est préchargé avec des données authentiques (FONR), vous permettant d'ajuster les prévisions et les hypothèses pour déterminer la valeur intrinsèque de Fonar Corporation avec précision.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 85.7 | 89.9 | 97.6 | 98.6 | 102.9 | 107.7 | 112.8 | 118.1 | 123.7 | 129.5 |
| Revenue Growth, % | 0 | 4.95 | 8.52 | 1.08 | 4.3 | 4.71 | 4.71 | 4.71 | 4.71 | 4.71 |
| EBITDA | 19.1 | 23.5 | 31.7 | 24.6 | 28.3 | 28.7 | 30.1 | 31.5 | 33.0 | 34.5 |
| EBITDA, % | 22.33 | 26.08 | 32.43 | 24.95 | 27.46 | 26.65 | 26.65 | 26.65 | 26.65 | 26.65 |
| Depreciation | 4.9 | 5.5 | 8.5 | 8.8 | 8.9 | 8.2 | 8.6 | 9.0 | 9.5 | 9.9 |
| Depreciation, % | 5.73 | 6.16 | 8.75 | 8.93 | 8.66 | 7.65 | 7.65 | 7.65 | 7.65 | 7.65 |
| EBIT | 14.2 | 17.9 | 23.1 | 15.8 | 19.3 | 20.5 | 21.4 | 22.5 | 23.5 | 24.6 |
| EBIT, % | 16.6 | 19.92 | 23.69 | 16.03 | 18.8 | 19.01 | 19.01 | 19.01 | 19.01 | 19.01 |
| Total Cash | 36.8 | 44.5 | 48.8 | 51.3 | 56.5 | 53.7 | 56.3 | 58.9 | 61.7 | 64.6 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 55.6 | 61.2 | 66.5 | 70.2 | 79.8 | 75.4 | 78.9 | 82.6 | 86.5 | 90.6 |
| Account Receivables, % | 64.94 | 68.05 | 68.11 | 71.13 | 77.61 | 69.97 | 69.97 | 69.97 | 69.97 | 69.97 |
| Inventories | 1.6 | 1.7 | 2.4 | 2.6 | 2.7 | 2.5 | 2.6 | 2.7 | 2.8 | 3.0 |
| Inventories, % | 1.92 | 1.85 | 2.42 | 2.6 | 2.64 | 2.29 | 2.29 | 2.29 | 2.29 | 2.29 |
| Accounts Payable | 2.0 | 1.9 | 1.6 | 1.6 | 1.9 | 2.0 | 2.1 | 2.2 | 2.3 | 2.4 |
| Accounts Payable, % | 2.29 | 2.07 | 1.59 | 1.6 | 1.8 | 1.87 | 1.87 | 1.87 | 1.87 | 1.87 |
| Capital Expenditure | -7.6 | -4.8 | -4.6 | -4.3 | -.8 | -5.2 | -5.5 | -5.7 | -6.0 | -6.3 |
| Capital Expenditure, % | -8.92 | -5.36 | -4.75 | -4.4 | -0.79978 | -4.84 | -4.84 | -4.84 | -4.84 | -4.84 |
| Tax Rate, % | 45.15 | 45.15 | 45.15 | 45.15 | 45.15 | 45.15 | 45.15 | 45.15 | 45.15 | 45.15 |
| EBITAT | 11.8 | 13.9 | 17.5 | 9.4 | 10.6 | 14.3 | 15.0 | 15.7 | 16.5 | 17.2 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -46.3 | 8.9 | 15.1 | 10.0 | 9.2 | 22.2 | 14.6 | 15.3 | 16.0 | 16.8 |
| WACC, % | 7.88 | 7.81 | 7.79 | 7.59 | 7.54 | 7.72 | 7.72 | 7.72 | 7.72 | 7.72 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 68.9 | |||||||||
| Long Term Growth Rate, % | 0.50 | |||||||||
| Free cash flow (T + 1) | 17 | |||||||||
| Terminal Value | 233 | |||||||||
| Present Terminal Value | 161 | |||||||||
| Enterprise Value | 230 | |||||||||
| Net Debt | -15 | |||||||||
| Equity Value | 244 | |||||||||
| Diluted Shares Outstanding, MM | 6 | |||||||||
| Equity Value Per Share | 37.73 |
What You Will Get
- Real FONR Financial Data: Pre-filled with FONAR Corporation’s historical and projected data for precise analysis.
- Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
- Automatic Calculations: See FONAR Corporation’s intrinsic value update instantly based on your changes.
- Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
- User-Friendly Design: Simple structure and clear instructions for all experience levels.
Key Features
- 🔍 Real-Life FONR Financials: Pre-filled historical and projected data for FONAR Corporation (FONR).
- ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
- 📊 Professional DCF Valuation: Built-in formulas calculate FONAR’s intrinsic value using the Discounted Cash Flow method.
- ⚡ Instant Results: Visualize FONAR’s valuation instantly after making changes.
- Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.
How It Works
- 1. Access the Template: Download and open the Excel file featuring FONAR Corporation’s (FONR) preloaded data.
- 2. Modify Assumptions: Adjust key inputs such as growth rates, WACC, and capital expenditures.
- 3. Instant Results: The DCF model automatically calculates intrinsic value and NPV in real-time.
- 4. Explore Scenarios: Analyze various forecasts to evaluate different valuation outcomes.
- 5. Present with Assurance: Deliver professional valuation insights to bolster your decision-making process.
Why Choose FONAR Corporation (FONR)?
- Innovative Technology: Cutting-edge imaging solutions that enhance diagnostic capabilities.
- Proven Track Record: Established history of delivering reliable and effective medical devices.
- Patient-Centric Approach: Focused on improving patient outcomes through advanced technology.
- Expert Support: Dedicated team of professionals available to assist with your needs.
- Industry Recognition: Trusted by healthcare providers and recognized for excellence in the field.
Who Should Use This Product?
- Healthcare Professionals: Understand advanced imaging techniques and their applications in real-world scenarios.
- Researchers: Utilize FONAR's innovative technologies in academic studies and clinical research.
- Investors: Evaluate your investment strategies and assess the market performance of FONAR Corporation (FONR).
- Medical Analysts: Enhance your analysis with a tailored financial model specific to the healthcare industry.
- Entrepreneurs: Discover how leading companies like FONAR are positioned in the medical imaging market.
What the Template Contains
- Comprehensive DCF Model: Editable template with detailed valuation calculations for FONAR Corporation (FONR).
- Real-World Data: FONAR’s historical and projected financials preloaded for analysis.
- Customizable Parameters: Adjust WACC, growth rates, and tax assumptions to test various scenarios.
- Financial Statements: Full annual and quarterly breakdowns for deeper insights into FONAR Corporation (FONR).
- Key Ratios: Built-in analysis for profitability, efficiency, and leverage specific to FONAR Corporation (FONR).
- Dashboard with Visual Outputs: Charts and tables for clear, actionable results related to FONAR Corporation (FONR).
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.